TruRadDose®

TruRadDose® analyzes the radiation dose delivered to patients based on their breast density instead of the dose estimated by the equipment manufacturer.

23 m+

Women have had their breast density assessed by our products.

9,500+

Mammography technologists rely on our products to improve mammogram quality.

10,000+

Sites across 65+ countries use Lunit.

Mean glandular dose (MGD)

Radiation dose in mammography is low, but the breast is a relatively radio-sensitive organ, and when millions of healthy women are being screened annually, it is important to ensure that the dose remains as low as reasonably possible while preserving diagnostic/screening image quality.

Mammography system manufacturers provide an MGD estimate for each image. However, several different algorithms exist for estimating MGD, and different ones have been chosen by each manufacturer.

One of the key inputs to those algorithms is breast density, and most use age and compressed breast thickness to infer breast density.

TruRadDose® achieves a patient-based result using the globally accepted and validated Dance model of dose estimation, and the volumetric breast density results for each digital breast tomosynthesis or 2D mammogram image.

Testimonials

“Without Volpara identifying this dose alert, we would have never known this was an issue. This shows the added benefit that Volpara brings to the table.”

Jonica Green, Director of Regulatory & Compliance
Jonica Green, Director of Regulatory & Compliance
Onsite Women's Health
Interested in Learning More About TruRadDose?

Interested in Learning More About TruRadDose?